GERM
Amplify Treatments, Testing and Advancements ETF
GERM
GERM
Delisted
GERM was delisted on the 5th of September, 2024.
25 hedge funds and large institutions have $9.29M invested in Amplify Treatments, Testing and Advancements ETF in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
25
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$811K | |
| 2 | +$475K | |
| 3 | +$456K | |
| 4 |
Belvedere Trading
Chicago,
Illinois
|
+$410K |
| 5 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$381K |
Top Sellers
| 1 | -$1.7M | |
| 2 | -$764K | |
| 3 | -$428K | |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$137K |
| 5 |
SFS
Sowell Financial Services
North Little Rock,
Arkansas
|
-$80K |